1. Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair
   Alexandra Khichfy Alex et al, 2017, Clinical Colorectal Cancer CrossRef
2. The Effects of Palliative Chemotherapy in Metastatic Colorectal Cancer Patients With an ECOG Performance Status of 3 and 4
   Marcela Crosara Teixeira et al, 2015, Clinical Colorectal Cancer CrossRef
3. Economic evaluations in gastroenterology in Brazil: A systematic review
   Luciana Bertocco de Paiva Haddad, 2016, WJGPT CrossRef
4. Estudos de custo-efetividade em saúde no Brasil: uma revisão sistemática
   Gabriele Moraz et al, 2015, Ciênc. saúde coletiva CrossRef
5. Conversion Chemotherapy With a Modified FLOX Regimen for Borderline or Unresectable Liver Metastases From Colorectal Cancer: An Alternative for Limited-Resources Settings
   Renata Colombo Bonadio et al, 2019, JGO CrossRef
6. Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community
   Bruno Mendonça Protásio et al, 2017, Clinical Colorectal Cancer CrossRef
7. Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline.
   E Gabriela Chiorean et al, 2020, JCO Glob Oncol CrossRef
8. Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review
   Koen Degeling et al, 2020, PharmacoEconomics CrossRef
9. Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer.
   Raphaela V Groehs et al, 2020, Oncologist CrossRef
10. Effects of palliative chemotherapy in unresectable or metastatic colorectal cancer patients with poor performance status.
    Lucila Soares da Silva Rocha et al, 2023, Clinical Colorectal Cancer CrossRef